SGLT2 Inhibitors Tied to Uptick in Hemoglobin and Hematocrit
(MedPage Today) -- DENVER -- Treatment with SGLT2 inhibitors was linked with modest but statistically significant increases in hemoglobin and hematocrit levels across a broad spectrum of patient populations, according to a systematic review and...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.